The stock of 3D Signatures Inc (CVE:DXD) is a huge mover today! About 27,800 shares traded hands. 3D Signatures Inc (CVE:DXD) has risen 6.00% since October 26, 2016 and is uptrending. It has outperformed by 0.59% the S&P500.
The move comes after 7 months negative chart setup for the $42.78 million company. It was reported on Nov, 25 by Barchart.com. We have $0.83 PT which if reached, will make CVE:DXD worth $2.14 million less.
More notable recent 3D Signatures Inc (CVE:DXD) news were published by: Marketwired.com which released: “3D Signatures Inc. Announces Closing of Qualifying Transaction” on September 09, 2016, also Marketwired.com with their article: “3D Signatures Inc. Appoints Jason Flowerday as New CEO” published on September 27, 2016, Marketwired.com published: “3D Signatures Inc. and Plicit Capital Corp. Increase Minimum Financing and …” on May 26, 2016. More interesting news about 3D Signatures Inc (CVE:DXD) were released by: Marketwired.com and their article: “3D Signatures Inc. Commences Trading September 13th Under the Symbol (TSX …” published on September 12, 2016 as well as Marketwired.com‘s news article titled: “3D Signatures Inc. Announces Brokered Private Placement” with publication date: November 17, 2016.
3D Signatures Inc, formerly Plicit Capital Corp, is a Canada personalized medicine firm with a software platform based on the three-dimensional analysis of telomere organization. The company has a market cap of $42.78 million. The Company’s software technology and prognostic methodology targets various diseases that demonstrate genomic instability, including cancer and neurological disorders. It currently has negative earnings. It is engaged in developing over five diagnostic and prognostic products for cancers and neurological disorders, including 3D Telo-PC, 3D Telo-RS, 3D Telo-MM, 3D Telo-BC, 3D Telo-LC and 3D Telo-AD.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.